Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wise

Showing results (311-320 of 335) with videos related to

Pageof 34
Sort By:
Cancer Immunology, Immunotherapy : CII|August 19, 2017
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibodyKar Muthumani, Liron Marnin, Sagar B Kudchodkar, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 1998
Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndromeK E Nichols, D P Harkin, S Levitz, et al.
Mucosal Immunology|May 7, 2015
Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challengeM A Kutzler, M C Wise, N A Hutnick, et al.
Molecular Cancer Research : MCR|December 11, 2020
AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin SignalingSizhi Paul Gao, Amber J Kiliti, Kai Zhang, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 17, 2014
Advances in geroscience: impact on healthspan and chronic diseaseJohn B Burch, Alison Deckhut Augustine, Leslie A Frieden, et al.
NPJ Vaccines|December 22, 2017
DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infectionsSarah T C Elliott, Nicole L Kallewaard, Ebony Benjamin, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge regionYu Mi Ahn, Michael Clare, Carol L Ensinger, et al.
Molecular Cancer Therapeutics|August 26, 2017
The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2<sup>Hi</sup> Macrophages in Breast Cancer and Pancreatic Neuroendocrine TumorsAllison S Harney, George S Karagiannis, Jeanine Pignatelli, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2020
In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure-Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive ImmunityZiyang Xu, Megan C Wise, Neethu Chokkalingam, et al.
Nature Communications|September 23, 2017
An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge modelAmi Patel, Antonio DiGiandomenico, Ashley E Keller, et al.
Pageof 34

Showing results (311-320 of 335) with videos related to

Sort By:
Pageof 34
Cancer Immunology, Immunotherapy : CII|August 19, 2017
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibodyKar Muthumani, Liron Marnin, Sagar B Kudchodkar, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 1998
Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndromeK E Nichols, D P Harkin, S Levitz, et al.
Mucosal Immunology|May 7, 2015
Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challengeM A Kutzler, M C Wise, N A Hutnick, et al.
Molecular Cancer Research : MCR|December 11, 2020
AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin SignalingSizhi Paul Gao, Amber J Kiliti, Kai Zhang, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 17, 2014
Advances in geroscience: impact on healthspan and chronic diseaseJohn B Burch, Alison Deckhut Augustine, Leslie A Frieden, et al.
NPJ Vaccines|December 22, 2017
DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infectionsSarah T C Elliott, Nicole L Kallewaard, Ebony Benjamin, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge regionYu Mi Ahn, Michael Clare, Carol L Ensinger, et al.
Molecular Cancer Therapeutics|August 26, 2017
The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2<sup>Hi</sup> Macrophages in Breast Cancer and Pancreatic Neuroendocrine TumorsAllison S Harney, George S Karagiannis, Jeanine Pignatelli, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2020
In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure-Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive ImmunityZiyang Xu, Megan C Wise, Neethu Chokkalingam, et al.
Nature Communications|September 23, 2017
An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge modelAmi Patel, Antonio DiGiandomenico, Ashley E Keller, et al.
Pageof 34